tiprankstipranks
Advertisement
Advertisement

Jin Medical Regains Nasdaq Bid-Price Compliance After Reverse Share Split

Story Highlights
  • Jin Medical regained Nasdaq minimum bid price compliance on April 2, 2026, after its shares stayed above $1.00 for 13 consecutive business days.
  • To address a 2025 bid-price deficiency and delisting risk, Jin Medical executed a 1-for-20 share consolidation in March 2026, resetting its capital structure while preserving its U.S. listing.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Jin Medical Regains Nasdaq Bid-Price Compliance After Reverse Share Split

Claim 55% Off TipRanks

Jin Medical International Ltd. ( (ZJYL) ) just unveiled an update.

On April 2, 2026, Jin Medical International Ltd. received notice from Nasdaq that it had regained compliance with the exchange’s minimum bid price rule after its Class A shares closed at or above $1.00 for 13 consecutive business days from March 16 to April 1, 2026. This follows a deficiency notice issued in May 2025 and two 180-day grace periods, during which the company implemented a 1-for-20 share consolidation effective March 16, 2026, to support its stock price.

After the reverse split, Jin Medical’s authorized capital was set at 45 million Class A and 5 million Class B ordinary shares, with 6,827,355 Class A and 1,000,000 Class B shares outstanding as of April 7, 2026. Regaining compliance removes an immediate delisting risk and stabilizes the company’s U.S. listing status, allowing management to refocus attention on core operations and strategic initiatives in the rehabilitation equipment market.

More about Jin Medical International Ltd.

Jin Medical International Ltd. is a NASDAQ-listed Chinese provider of rehabilitation medical equipment, specializing in the design, development, manufacturing and marketing of wheelchairs and living aids for people with disabilities, the elderly and rehabilitation users. Founded in 2006 and headquartered in Changzhou, Jiangsu Province, it operates two plants in Jiangsu and is building a larger facility in Anhui, selling over 30 wheelchair models mainly through distributors in Japan and China.

The company works with more than 40 distributors in China and over 20 internationally, leveraging a network-driven model to expand its reach in key Asian markets. Its products emphasize lightweight and ergonomic designs, positioning Jin Medical in the growing mobility and rehabilitation equipment segment as demand rises with aging populations and increased focus on accessible care.

Average Trading Volume: 41,837

Technical Sentiment Signal: Strong Sell

Current Market Cap: $15.5M

See more insights into ZJYL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1